C07C 217/14
The oxygen atom of the etherified hydroxy group being further bound to
Official title: the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
C07C217/14 (The oxygen atom of the etherified hydroxy group being further bound to) appears on 386 US grants and 342 published applications in this corpus.
Search patents in C07C- Granted patents
- 386
- Published applications
- 342
- Assignees
- 258
- Inventors
- 1,110
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 7 | 0 |
| 1990 | 1 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 9 | 0 |
| 1994 | 5 | 0 |
| 1995 | 13 | 0 |
| 1996 | 18 | 0 |
| 1997 | 16 | 0 |
| 1998 | 10 | 0 |
| 1999 | 7 | 0 |
| 2000 | 9 | 0 |
| 2001 | 11 | 5 |
| 2002 | 13 | 12 |
| 2003 | 9 | 17 |
| 2004 | 10 | 24 |
| 2005 | 13 | 21 |
| 2006 | 16 | 24 |
| 2007 | 11 | 15 |
| 2008 | 22 | 17 |
| 2009 | 9 | 14 |
| 2010 | 10 | 9 |
| 2011 | 7 | 12 |
| 2012 | 10 | 15 |
| 2013 | 14 | 19 |
| 2014 | 19 | 13 |
| 2015 | 16 | 22 |
| 2016 | 20 | 11 |
| 2017 | 7 | 12 |
| 2018 | 9 | 8 |
| 2019 | 4 | 6 |
| 2020 | 6 | 8 |
| 2021 | 6 | 10 |
| 2022 | 6 | 9 |
| 2023 | 7 | 9 |
| 2024 | 7 | 10 |
| 2025 | 8 | 13 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nitrogen-branched non-linear pegylated lipid containing a tertiary amine and application thereof18 Aug 2026US 12,708,675 B2Xiamen Sinopeg Biotech Co., Ltd.
- Visible light active biomass derived photoinitiators5 May 2026US 12,617,751 B2Bowling Green State University
- PDIA4 inhibitors and use thereof for inhibiting β-cell pathogenesis and treating diabetes21 Apr 2026US 12,605,353 B2Academia Sinica
- Methods for making and using endoxifen25 Nov 2025US 12,479,790 B2Atossa Therapeutics, Inc.
- Molecular design of new antibiotics and antibiotic adjuvants against MCR strains18 Nov 2025US 12,473,250 B2Agency for Science, Technology and Research
- Methods for making and using endoxifen24 Sep 2026US 2026/0285798 A1Atossa Therapeutics, Inc.
- Methods for making and using endoxifen16 Jul 2026US 2026/0200827 A1Atossa Therapeutics, Inc.
- Methods for making and using endoxifen16 Jul 2026US 2026/0200828 A1Atossa Therapeutics, Inc.
- Methods for making and using endoxifen16 Jul 2026US 2026/0200829 A1Atossa Therapeutics, Inc.
- Endoxifen compositions and methods of use thereof and synthesis thereof4 Jun 2026US 2026/0151360 A1Atossa Therapeutics, Inc.
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009
- Stilbene derivatives as anticancer agents78US 5,430,062 AResearch Corporation Technologies, Inc. · 1995
- High affinity tamoxifen derivatives and uses thereof71US 5,192,525 ABoard of Regents, The University of Texas System · 1993